← Open Payments lookup

JOHN SHIPP: Open Payments

NPI 1801027453 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$693 in 35 payments from 13 companies in 2025. Trend: 2023 $759 · 2024 $701 · 2025 $693

Food & beverage: $693
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$158
Astellas Pharma US Inc4$87
ABBVIE INC.5$77
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$71
Optinose US, Inc.3$56
Abbott Laboratories3$54
Novo Nordisk Inc2$49
Lilly USA, LLC2$43
Phathom Pharmaceuticals, Inc.1$26
Xeris Pharmaceuticals, Inc.1$25

Products named: AIRSUPRA, Veozah, CAPLYTA, QULIPTA, Xhance, FREESTYLE LIBRE 3, MOUNJARO, FARXIGA.

Industry payments across AZ — which companies pay providers there.